ARNICA MONTANA - CITRULLUS COLOCYNTHIS FRUIT PULP - PSEUDOGNAPHALIUM OBTUSIFOLIUM - HYPERICUM PERFORATUM - POTASSIUM IODIDE - MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE - TOXICODENDRON PUBESCENS LEAF -

FDA Drug Profile — Sciatica Therapy

ARNICA MONTANA - CITRULLUS COLOCYNTHIS FRUIT PULP - PSEUDOGNAPHALIUM OBTUSIFOLIUM - HYPERICUM PERFORATUM - POTASSIUM IODIDE - MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE - TOXICODENDRON PUBESCENS LEAF - is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Sciatica Therapy. Available dosage form: tablet, orally disintegrating.

Drug details

Generic Name
ARNICA MONTANA - CITRULLUS COLOCYNTHIS FRUIT PULP - PSEUDOGNAPHALIUM OBTUSIFOLIUM - HYPERICUM PERFORATUM - POTASSIUM IODIDE - MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE - TOXICODENDRON PUBESCENS LEAF -
Brand Names
Sciatica Therapy
Sponsor
TRP Company
NDC Codes
1
Dosage Forms
TABLET, ORALLY DISINTEGRATING
Routes
ORAL
Active Ingredients
ARNICA MONTANA, CITRULLUS COLOCYNTHIS FRUIT PULP, PSEUDOGNAPHALIUM OBTUSIFOLIUM, HYPERICUM PERFORATUM, POTASSIUM IODIDE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, TOXICODENDRON PUBESCENS LEAF

Indications and Usage

Uses: According to homeopathic indications these ingredients provide temporary relief from symptoms of Sciatica such as: • back aches • nerve discomfort • leg numbness • tingling legs • shooting discomfort • stiffness • tearing pain after serious causes have been ruled out by a physician. * These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.

Warnings

Warnings: A PHYSICIAN SHOULD ALWAYS BE CONSULTED TO RULE OUT SERIOUS CAUSES. This product is intended to complement, not replace, standard medical treatment. Initial worsening of symptoms may occur. A physician should always be consulted regarding Sciatica to rule out serious causes. In case of overdose, get medical help or contact a Poison Control Center right away. Stop use and ask a doctor if: • Symptoms persist for more than 7 days or worsen, if new symptoms occur or if redness or swelling is present because these could be a sign of a serious illness.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.